2022 mid-year highlights in Canadian life sciences IP and regulatory law | Smart & Biggar

In the first half of 2022, Rx IP Update reported on a number of developments in Canadian life sciences IP and regulatory law. The Rx IP Update team at Smart & Biggar has collected the...

Related Keywords

Canada ,Quebec ,Canadian ,Janssenv Pharmascience ,Janssenv Sandoz ,Janssenv Apotex ,Urszula Wojtyra ,Alice Tseng ,Pharmasciencev Teva ,Meta Facebook ,Allerganv Apotex ,Instagram ,Health Canada Forward Regulatory Plan ,Quebec Court ,Meta Platforms Inc ,Facebook ,Health Canada ,Merck Sharp Dohme Corpv Pharmascience ,Competition Bureau ,Patented Medicines Regulationswere ,Patented Medicines Regulations ,Federal Court ,Forward Regulatory Plan ,Advanced Therapeutic Products Pathway ,Adaptive Machine Learning Enabled Medical Devices ,Drug Regulations ,Final Report ,Building Toward ,Potential Pan Canadian Formulary ,Federal Courts ,Patented Medicines ,Dohme Corp ,Competition Act In June ,Meta Platforms ,